Literature DB >> 23522435

Occupational exposure to immunologically active agents and risk for lymphoma: the European Epilymph case-control study.

Ana Espinosa1, Jan-Paul Zock, Yolanda Benavente, Paolo Boffetta, Nikolaus Becker, Paul Brennan, Pierluigi Cocco, Lenka Foretova, Marc Maynadié, Anthony Staines, Alexandra Nieters, Manolis Kogevinas, Silvia de Sanjose.   

Abstract

OBJECTIVES: Allergies and asthma may be protective for the development of lymphoma. We evaluated whether occupational allergens that provoke immune reactivity and asthma through an IgE-mediated pathway are protective for lymphoma.
METHODS: The Epilymph study includes histologically or cytologically confirmed Hodgkin, B-cell, and T-cell lymphoma cases from six European countries (Spain, France, Germany, Italy, Ireland, and Czech Republic) recruited in 1998-2004. Controls were frequency matched to cases by age, gender, and study centre. Lifetime occupational exposure to seven high molecular weight (HMW) agents was evaluated through an asthma-specific job-exposure matrix. 2205 lymphoma cases and 2296 controls with complete occupational history could be included in the analysis. Associations between HMW exposures and lymphoma were evaluated using pooled unconditional logistic regression analyses.
RESULTS: Individuals exposed to HMW agents had a non-statistically significant decreased risk of any lymphoma (OR, 0.88: 95% CI, 0.74-1.05) and of B-cell lymphoma (OR, 0.91; 95% CI, 0.76-1.09), and a significantly decreased risk for Hodgkin lymphoma (OR, 0.62; 95% CI, 0.40-0.98). A decrease in risk for lymphoma was found for exposure to latex (OR, 0.74; 95% CI, 0.55-0.99).
CONCLUSIONS: Further epidemiologic and mechanistic research is needed to confirm that occupational exposure to HMW agents predisposing to asthma can reduce the risk of lymphoma.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23522435     DOI: 10.1016/j.canep.2013.02.006

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  5 in total

1.  Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.

Authors:  Lynn I Levin; Elizabeth C Breen; Brenda M Birmann; Julie L Batista; Larry I Magpantay; Yuanzhang Li; Richard F Ambinder; Nancy E Mueller; Otoniel Martínez-Maza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-03-24       Impact factor: 4.254

2.  Farm characteristics, allergy symptoms, and risk of non-hodgkin lymphoid neoplasms in the agricultural health study.

Authors:  Jonathan N Hofmann; Jane A Hoppin; Charles F Lynch; Jill A Poole; Mark P Purdue; Aaron Blair; Michael C Alavanja; Laura E Beane Freeman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-12       Impact factor: 4.254

Review 3.  CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's Lymphomas.

Authors:  Alexandra S Onea; Ali R Jazirehi
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

4.  Occupational ultraviolet exposure and risk of non-Hodgkin's lymphomas: a meta-analysis.

Authors:  Demin Lu; Fei Xu; Kaiming Hu; Li Yin; Huijie Duan; Jiaojiao Zhang; SuZhan Zhang
Journal:  Oncotarget       Date:  2017-05-24

5.  Occupational exposure to organic dust and risk of lymphoma subtypes in the EPILYMPH case-control study.

Authors:  Pierluigi Cocco; Giannina Satta; Federico Meloni; Ilaria Pilia; Fahad Ahmed; Nikolaus Becker; Delphine Casabonne; Silvia de Sanjosé; Lenka Foretova; Marc Maynadié; Alexandra Nieters; Anthony Staines; Andrea 't Mannetje; Mariagrazia Zucca; Maria Grazia Ennas; Marcello Campagna; Sara De Matteis; Yolanda Benavente
Journal:  Scand J Work Environ Health       Date:  2020-09-25       Impact factor: 5.024

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.